ABSTRACT Double-stranded oligonucleotides (ODNs) containing the consensus binding sequence of a transcription factor provide a rationally designed tool to manipulate gene expression at the transcriptional level by the decoy approach. However, modi®ca-tions introduced into oligonucleotides to increase stability quite often do not guarantee that transcription factor af®nity and/or speci®city of recognition are retained. We have previously evaluated the use of locked nucleic acids (LNA) in the design of decoy molecules for the transcription factor kB. Oligonucleotides containing LNA substitutions displayed high resistance to exo-and endonucleolytic degradation, with LNA±DNA mix-mers being more stable than LNA±DNA±LNA gap-mers. However, insertion of internal LNA bases resulted in a loss of af®nity for the transcription factor. This latter effect apparently depended on positioning of the internal LNA substitutions. Indeed, here we demonstrate that intra-and inter-strand positioning of internal LNAs has to be carefully considered to maintain af®nity and achieve high stability, respectively. Unfortunately, our data also indicate that LNA positioning is not the only parameter affecting transcription factor binding, the interference in part being dependent on the intrinsic conformational properties of this nucleotide analog. To circumvent this problem, the successful use of an a-L-ribocon®gured LNA is demonstrated, indicating LNA± DNA±a-L-LNA molecules as promising new decoy agents.
INTRODUCTION
The discovery that altered gene expression is an important component in the pathophysiology of many human diseases has provided unprecedented opportunities for the development of new therapeutics targeting disease processes at the level of gene function and control (1) . It is well known that tissue-and stimulus-speci®c gene expression is initiated and primarily regulated at the transcriptional level by sequence-speci®c protein/DNA interactions involving specialized proteins, termed transcription factors, with nucleotide regulatory elements found in gene promoters and enhancers (cis elements) (2, 3) . Therefore, as gene regulators, transcription factors have become an attractive target for potential therapeutic intervention (4±6). Indeed, a growing number of transcription factors that regulate changes in gene expression during the pathogenesis of a wide range of disorders have been identi®ed.
A large number of physical and biochemical studies have established that transcription factors display substantial diversity regarding both their structures and activation mechanisms, which are unique and hence suitable for the development of strategies for the selective targeting of these proteins (7) . One such strategy is the decoy approach, which provides a very direct and simple way to selectively inhibit the activity of any transcription factor simply knowing minimal structural features of the target, namely its DNA binding sequence (8±13). Conceptually, the approach is based on the evidence that each transcription factor or family of transcription factors recognizes speci®c DNA sequences termed the consensus binding sequence. Signi®cantly, this type of protein/DNA interaction also occurs in the absence of the surrounding genomic DNA. Therefore, synthetic oligodeoxynucleotides (ODNs) corresponding to the consensus binding sequence of a speci®c transcription factor have the potential to ef®ciently compete with the endogenous cis elements for transcription factor binding, allowing gene expression to be speci®cally modulated.
Although transcription factor decoys were initially used as a tool to study gene expression, their in vivo effectiveness has prompted the consideration of their use in therapy. E2F decoys are the ®rst double-stranded DNA molecules which have reached the stage of clinical trials, providing the very ®rst evidence that human gene expression can be modulated for therapeutic purposes using transcription factor decoys (14) . However, naturally unmodi®ed DNA molecules are subject to *To whom correspondence should be addressed. Tel: +39 0722 305211; Fax: +39 0722 320188; Email: magnani@uniurb.it relatively rapid degradation, primarily through the action of 3¢-exonucleases, but also as a result of endonuclease attack (15) . Therefore, in view of a more extensive clinical application, ODN decoys are now routinely modi®ed to enhance their biostability so as to improve their pharmacological properties. For this purpose, a variety of nucleic acid analogs containing modi®cations in the nucleobase, the sugar ring or the phosphodiester backbone have been synthesized and some of them, such as phosphorothioates and peptide nucleic acids (PNA), tested as decoy molecules (16, 17) . However, a major issue in this effort is represented by the possibility that bene®ts in terms of nuclease resistance may be negated by a decrease in the af®nity and/or speci®city of transcription factor binding to its target sequence. Fully modi®ed phosphorothioate oligonucleotides and PNA decoys have been demonstrated to be poorly speci®c or unable to form stable complexes with the target factor, respectively (17, 18) . These results highlight that for optimum activity decoy ODNs should possess a combination of various properties rather than exclusively either increased stability toward nucleases or high af®nity for the target transcription factor. Since the nature of the nucleotide and internucleotide linkages dictate the biophysical, biochemical and biological properties of oligonucleotides, the positioning of nucleotide analogs in a given sequence is crucial to the outcome and should be chosen carefully.
Despite impressive gains in structural biology over the past years, the effects produced by nucleotide modi®cation on DNA/protein interactions are still dif®cult to predict. For this reason, in an attempt to reach the optimal decoy design, several research groups have followed the most obvious path, i.e. to keep modi®cations outside the transcription factor consensus binding sequence. In principle, this approach provides a certain degree of stability toward nuclease action and at the same time excludes interference with transcription factor binding. In this view, terminally phosphorothioatemodi®ed molecules and PNA±DNA chimeras have recently been proposed as alternative decoy agents (19, 20) .
We have previously investigated the use of a new class of nucleic acid analogs, termed locked nucleic acids (LNAs), in the design of decoy oligonucleotides targeting nuclear transcription factor kB (NF-kB) (21) . LNA bases are nucleotide analogs containing a methylene linkage between the 2¢ oxygen and the 4¢ carbon of the ribose ring (22±24). Thus, oligomers that contain LNA bases have a native phosphate backbone. Furthermore, LNAs are assembled using conventional phosphoramidite chemistry, allowing LNA nucleotides to be easily interspersed among DNA nucleotides, permitting the properties of the chimerical LNA±DNA molecules to be ®ne tuned for optimized decoy drug development (23, 24) . Our previous results demonstrated that inclusion of at least two terminal LNA monomers in a decoy molecule, outside the NF-kB binding sequence (kB site), appreciably increased protection against nuclease digestion without interfering with transcription factor binding (21) . Signi®cant further stabilization was achieved when LNA monomers were included in the kB site as well. However, replacement of internal nucleotides with LNAs resulted in a loss of af®nity of NF-kB for its target sequence. Interestingly, this latter effect was apparently dependent on positioning of the internal LNA substitutions (21) . Thus, in an attempt to reconcile biostability with af®nity, the possible role of the intra-and inter-strand positioning of LNAs in affecting NF-kB binding and in conferring resistance to nuclease digestion has been further investigated here.
MATERIALS AND METHODS

Oligonucleotides
Oligonucleotides containing LNA substitutions were obtained as HPLC-puri®ed products on the 0.2 mmol scale from Proligo LLC (Boulder, CO and Paris, France). DNA±LNA mix-mers containing terminal LNA and internal a-L-ribo-con®gured LNA (a-L-LNA) monomers were prepared by the phosphoramidite approach as already described (25, 26) . After deprotection and cleavage from the solid support, DNA±LNA±a-L-LNA oligomers were puri®ed by DMT-on reversed phase chromatography on disposable puri®cation cartridges which includes detritylation. The composition was con®rmed by MALDI-MS analysis and the purity (>90%) by capillary gel electrophoresis. Isosequential phosphodiester oligonucleotides, used as controls, were purchased from Sigma Genosys (Cambridge, UK) as HPLC-puri®ed products.
All oligomers were quantitated based on spectrophotometric A 260 and the conversion factor of 30.4 mg/ml OD 260 (sense strand) and 32.1 mg/ml OD 260 (antisense strand) as indicated for the corresponding phosphodiester oligonucleotides by the manufacturer. Upper and reverse complement strands were hybridized in TE buffer (10 mM Tris±HCl, 1 mM EDTA, pH 8.0) to obtain stock solutions of double-stranded decoy molecules at a ®nal concentration of 40 mM. Annealing was performed in a thermocycler according to the following temperature pro®le: 5 min at 100°C, followed by a temperature reduction to 37°C over 60 min and from 37 to 4°C over 30 min.
Cell stimulation and nuclear extract preparation
HeLa cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum at 37°C in a humidi®ed 5% CO 2 incubator. Cells were plated at a density of 5 Q 10 5 cells/60 mm diameter culture dish. The day after, cells were stimulated with 1 ng/ml tumor necrosis factor-a (TNF-a) (Boeringher Mannheim Biochemia, Mannheim, Germany) for 1 h at 37°C. After stimulation, cells were washed and harvested with cold phosphate-buffered saline. Nuclear proteins were obtained by low salt/detergent cell lysis followed by high salt extraction of nuclei as previously described (21) .
Gel shift competition experiments
Nuclear extracts (0.4 mg/ml) from TNF-a-stimulated HeLa cells were preincubated with 0.2 mg/ml double-stranded nonspeci®c DNA competitor poly(dI´dC) (Amersham Pharmacia Biotech, Piscataway, NJ) for 10 min on ice in binding buffer (20 mM HEPES±KOH, pH 7.9, 0.1 M KCl, 5% v/v glycerol, 0.2 mM EGTA, 0.2 mM EDTA, 1 mM dithiothreitol). Aliquots of the mixture corresponding to 6 mg of nuclear extract were transferred to separate tubes and incubated with increasing concentrations of competitor ODN, either a phosphodiester or a LNA-modi®ed duplex as speci®ed. To this end, stock solutions (40 mM) of double-stranded decoy molecules were serially diluted 1:1.5 in TE buffer and added 
Serum stability assay
Phosphodiester and LNA-modi®ed oligonucleotides were incubated at 37°C in fresh human serum obtained from blood samples of healthy volunteers. Aliquots of the mixture corresponding to 0.75 mg double-stranded ODN were removed at different incubation times as indicated. Reactions were terminated by addition of EDTA and EGTA to ®nal concentrations of 10 and 5 mM, respectively. Samples were then immediately frozen in dry ice and stored at ±80°C. Full-length oligomers were separated from digested ODNs on a nondenaturing 2.5% (w/v) agarose gel. Bands were visualized by ethidium bromide staining using a Gel Doc 1000 apparatus. Densitometric calculations were done with Molecular Analyst imaging software (Bio-Rad Laboratories). The volume density of the band corresponding to full-length oligomers was calculated in each lane with correction for background. Average half-lives and standard deviations from at least three independent experiments for each oligonucleotide were obtained by ®tting the data to a single exponential decay function (Origin 6.0; Microcal Software).
RESULTS
Design of the decoy molecules
In a previous study we designed a panel of decoy oligonucleotides modi®ed to various extents and at various positions with LNA bases (21) . These oligonucleotides consisted of two kB sites, corresponding to the kB sequence contained in the PRDII domain of the human IFN-b promoter (Fig. 1, PRDII) , capped with unrelated extra sequences of 5 nt at both termini (Fig. 1, D+D ). Our results demonstrate that insertion of at least two terminal LNA monomers, outside the kB motifs (Fig. 1, B+B) , was suf®cient to confer appreciable protection against nuclease digestion, without interfering with transcription factor binding (21) . However, when LNA substitutions were also positioned within the kB sites, by modifying nucleotides in both strands (Fig. 3, C+C) , further increased stability was observed, although a considerable reduction in NF-kB binding af®nity was found (21) . Interestingly, when considering LNA substitutions in position C separately, the reduction in the NF-kB binding af®nity was more pronounced when the LNAs were in the antisense strand (Fig. 1, B+C) rather than in the sense strand (Fig. 1, C+B) (21) .
From a molecular point of view this effect could be explained by the fact that LNA nucleotides perturb the sugar puckers of the¯anking unmodi®ed nucleotides, predominantly in the 3¢ direction, from a preferential S-type pucker in DNA duplexes to a mixture of N-type and S-type conformations (27, 28) . The result is a local rearrangement of the phosphate backbone geometry toward the A-type helix. On the other hand, it is well known that NF-kB recognizes the decameric consensus sequence 5¢-GGGRNNYYCC-3¢ (N, any nucleotide; R, purine; Y, pyrimidine), where the transcription factor makes base-speci®c contacts mainly with the conserved G:C pairs at the ends of the site, lying in the major groove ( Fig. 1 , nucleotides in boxes). Thus, the core of the site, in the minor groove, usually remains open. Only in the case of PRDII do the High Mobility Group (HMG) I(Y) proteins speci®cally recognize and bind the central AT-rich sequence (29, 30) . As a consequence, we hypothesized that the differences observed in NF-kB binding af®nity for the C+B and B+C molecules could be due to the fact that the conformational modi®cations introduced by the LNAs in the sense strand (C+B) are mainly propagated to the AT-tract. Conversely, those introduced by the LNAs in antisense (B+C) presumably involve the GC-rich sequence, which is known to be particularly critical for interactions with NF-kB. Therefore, we reasoned that LNA decoys which are more ef®ciently recognized by NF-kB could be designed by a more convenient positioning of the internal LNA substitutions.
To test this hypothesis, nucleotides in positions C1 and C2 of the sense strand and nucleotides in positions C2 and C3 of the antisense strand were replaced with LNA monomers to obtain the decoy molecules shown in Figures 1 and 3 . These positions were chosen in order to preferentially restrict the conformational modi®cations, introduced by the LNA in the 3¢ direction, to the nucleotides of the central AT-rich segment in order to limit to the minor groove any potential structural alteration of the DNA geometry. In fact, it is worth noting that LNA substitutions in positions C2 and C1 of the sense strand and in positions C2 and C3 of the antisense strand are spaced from the ®rst G:C base pair in the 3¢ direction by two and three unmodi®ed nucleotides, respectively.
Insertion of LNAs in the kB site differentially affects NF-kB binding af®nity depending on their intra-strand positioning
In order to establish whether or not a relationship exists between LNA intra-strand positioning and NF-kB binding af®nity, the ability of NF-kB to bind ODN decoys containing internal LNA substitutions in only one strand was evaluated by electrophoretic mobility shift assay (EMSA) (Fig. 1) . Because LNA ODNs are not ef®ciently phosphorylated on the 5¢ end (21,31), they could not be used in direct binding assays where high speci®c activity of the probe is required. For this reason, NF-kB binding to the different LNA decoys was indirectly assessed by means of gel shift competition experiments from which the concentration of each LNA-modi®ed molecule required to displace 50% of the non-modi®ed 32 P-labeled probe (IC 50 value) was determined. Indeed, on the assumption that the competition ef®ciency is proportional to the binding af®nity, the IC 50 value provides a good measure of the relative af®nity of NF-kB for the different LNA ODNs tested with respect to the isosequential unmodi®ed molecule. This type of correlation also implies that as the IC 50 value decreases, NFkB binding af®nity increases and vice versa. Therefore, this approach was used to quantify the effects produced by the insertion of LNA bases in the PRDII kB motif on the NF-kB/ DNA interactions, which we intended to investigate in these experiments. Binding assays were performed by incubating crude nuclear extracts from TNF-a-stimulated HeLa cells with increasing concentrations of unlabeled LNA ODNs together with a ®xed amount of the [ 32 P]PRDII probe. The concentration of the radiolabeled DNA used in the competition assays was ®rst determined in bandshift titration experiments to make sure that the amount of probe exceeded that of NF-kB present in the incubation mixture (data not shown). A single protein/DNA complex was detected (Fig. 1, lanes 1) . Speci®city of complex formation was demonstrated by the complete disappearance of the radiographic signal upon addition of a 60 molar excess of a DNA molecule encompassing the kB sequence contained in the enhancer of the immunoglobulin light chain gene (Ig-kB) (data not shown). The same result was not obtained when a mutagenized Ig-kB DNA ODN was used as competitor, con®rming that the complex was speci®c for the NF-kB site (data not shown). The results of the competition experiments are presented in Figure 1 , which shows a progressive reduction in the radiographic signal corresponding to the NF-kB/[ 32 P]PRDII complex upon addition of the indicated LNA ODN competitors. Unexpectedly, this reduction was signi®cantly faster for the C1+B and B+C3 molecules with respect to C2+B and B+C2 (Fig. 1) , indicating that insertion of LNA monomers in position C2 of the kB site caused a drastic decrease in the capacity of the molecule to act as competitor. Indeed, at the concentrations at which C1+B and B+C3 induced complete disappearance of the radiographic signal, C2+B and B+C2 were still unable to ef®ciently remove NF-kB from binding with the radiolabeled PRDII DNA (Fig. 1, compare lanes 11±  14) . In agreement with these observations, the calculated IC 50 values of C2+B (197.4 nM) and B+C2 (209.7 nM) were 20-and 15-fold higher than those of C1+B (9.67 nM) and B+C3 (13.78 nM), respectively (Table 1 ). In contrast, the NF-kB binding activity was signi®cantly improved when LNAs in position C were transferred to position C1 in the sense strand, as determined by a decrease of 1.8-fold of the IC 50 value of C1+B in comparison with that calculated for C+B, under the same experimental conditions (Table 1) . Similar results were obtained when LNAs of the antisense strand were moved from position C to position C3, with a 2.2-fold decrease in the IC 50 Figure 1 . Design of the ODNs containing internal LNA substitutions only in one strand and competition of these molecules for binding of NF-kB to the radiolabeled PRDII probe. Oligonucleotides were derived from an ODN of 30 bp, consisting of two PRDII kB sites in tandem (10 bp each, shown in braces), extended at the terminal ends with unrelated extra sequences of 5 nt (D+D, 30 bp) and modi®ed by replacing the two terminal nucleotides with LNA monomers on both strands (B+B). Lower case, DNA monomers; bold upper case in grey, LNA bases. Besides the LNA end-block, additional LNA substitutions were introduced in the kB sequences at different positions other than C, tested in a previous study, of the sense (C1, C2) or of the antisense (C2, C3) strand, as indicated by the arrows. In replacing internal nucleotides with LNAs, those which establish base-speci®c contacts with NF-kB (in boxes) have been excluded. The ability of NF-kB to bind these molecules was assessed by gel shift competition experiments as described in Materials and Methods. Only the protein/probe complex is shown. Competitor concentrations in lanes 2±14 were 2. (Table 1) .
Taken together these results demonstrate that NF-kB binding af®nity can be ®ne tuned by appropriate substitution of the nucleotides in the kB sequence taking into account that the degree of interference related to LNA positioning decreased as follows: C2 > C > C1 in the sense strand; C2 > C > C3 in the antisense strand (Table 1) .
Insertion of LNAs in position C2 directly affects interactions between NF-kB and its binding sequence
Since in the PRDII kB site nucleotides of the central AT-tract bind HMG I(Y) proteins (32, 33) , the next step was to evaluate whether the crucial role played by the LNAs in position C2 was an HMG I(Y)-dependent effect. To this end, we designed oligonucleotide decoys in which both the PRDII kB motifs were replaced with the kB consensus sequence (Ig-kB) present in the enhancer of the immunoglobulin light chain gene (Igk) (Fig. 2) . The two kB sequences essentially differ in the identity of two of the variable inner base pairs: in the PRDII kB site these are 5¢-AAATT-3¢, while in the Ig-kB site they are 5¢-ACTTT-3¢. Thus, the latter does not bind HMG I(Y) proteins (33) . Interestingly, when nucleotides in position C and C2 (sense strand) of the Ig-kB sites were substituted with LNAs, a marked difference in the competitive action of the C+B and C2+B ODNs in gel shift experiments was again found (Fig. 2) . In fact, if compared to the C+B ODN, the ef®ciency of C2+B in competing with the [ 32 P]PRDII probe for NF-kB binding was markedly lower, as demonstrated by an IC 50 value of C2+B (134.8 nM) 15-fold higher than that of C+B (8.76 nM) ( Table 1 ). These results demonstrate that the LNAs in C2 remain critical in the context of other kB sites, suggesting that replacement of nucleotides in position C2 with LNAs directly affects interactions between NF-kB and its consensus binding sequence.
The intra-and inter-strand positioning of LNA substitutions have additive effects on NF-kB binding Insertion of LNA substitutions on both strands is expected to have more pronounced effects on the geometry of the DNA duplex than substitutions on a single strand since the total number of LNA bases introduced in the molecule increases. In addition, the LNA inter-strand positioning could also confer different degrees of interference according to whether LNA bases occupy complementary or non-complementary positions and how these latter are spaced along the sequence. For these reasons, the ability of NF-kB to bind molecules containing internal LNAs on both strands and at different positions was evaluated as well. Again, NF-kB displayed a markedly lower af®nity for oligonucleotides containing LNAs in position C2 when compared to the others (Fig. 3 , compare C2+C2 and C+C2 with C1+C3 and C+C3). Indeed, IC 50 values of these molecules were shifted to the micromolar concentration range (Fig. 4 and Table 1 ). In contrast, estimated IC 50 values of C1+C3 and C+C3 molecules were 93.97 and 98.64 nM, respectively (Fig. 4 and Table 1 ). These values were not signi®cantly different, indicating that transfer of the LNAs from position C to C1 of the sense strand had no effects on NFkB binding. According to the above established intra-strand rules, this result is unexpected, unless a contribution of interstrand positioning is invoked. Although in terms of intrastrand positioning substitutions in C (sense strand) interfere with NF-kB binding more than those in C1 (sense strand), C is separated from C3 by two unmodi®ed nucleotides in C+C3, while C1 is separated from C3 by only one unmodi®ed nucleotide in C1+C3 (Fig. 3) . A signi®cantly increased af®nity for NF-kB was observed only when LNAs in position C of the antisense strand were moved to C3. This is demonstrated by a 1.7-fold decrease in the IC 50 value of C+C3 in comparison with that calculated for the previously tested C+C molecule ( Table 1 ). In this case also a cooperative role of the inter-and intra-strand positioning might contribute to increase the af®nity of NF-kB for C+C3 with respect to C+C, with the LNA substitutions in this latter case being positioned on complementary nucleotides (Fig. 3 ). C+C3 and C1+C3 were the molecules with internal LNA substitutions on both strands with the best NF-kB af®nities of all the decoys tested ( Fig. 4 and Table 1 ).
Increased resistance to nuclease degradation depends on the inter-strand positioning of the LNA substitutions in the kB site
Since the ideal decoy molecule should not only be ef®ciently recognized by the target transcription factor but also stable in biological media, the susceptibility to nuclease degradation of the LNA decoys was evaluated by incubating these molecules Figure 2 . Gel shift competition experiments with LNA ODNs in which the PRDII kB site has been replaced with the Ig-kB site. LNA ODNs were designed by replacing the internal PRDII kB sites with the kB motif found in the enhancer of the immunoglobulin light chain gene (Ig-kB, in braces), while the extra sequences having the LNA end-block were maintained unchanged. Nucleotides of the Ig-kB sequences on the sense strand which occupy the positions corresponding to C or C2 on the sense strand of the PRDII kB motifs were replaced with LNAs (bold upper case in grey). The ability of NF-kB to bind these molecules was tested in gel shift competition experiments as described in Materials and Methods. in human serum. Based on our previous observation that introduction of additional internal LNAs in only one strand is not suf®cient to confer a higher stability with respect to that obtained with a simple LNA end-block (21) , only molecules where internal LNA substitutions were placed in both strands have been tested in these experiments. Aliquots of the mixture were taken at the indicated time points and analyzed by electrophoresis on non-denaturing agarose gels followed by ethidium bromide staining (results of a typical experiment are shown in Fig. 5) . Disappearance of the double-stranded decoy molecule was considered proof of degradation by serum nucleases. The area of the uncleaved fraction was densitometrically evaluated and plotted as a function of the incubation time. Figure 5 shows the results for the ODNs containing, other than the LNA end-block, additional internal LNA substitutions in both strands in different positions, involving either complementary (Fig. 3, C+C and C2+C2 ) or noncomplementary (Fig. 3, C1+C3 , C+C2 and C+C3) nucleotides, in comparison with the results obtained for endblocked ODN B+B (Fig. 1) as well as the reference DNA molecule D+D (Fig. 1) . Due to the higher resistance to nuclease degradation of double-stranded DNA with respect to single-stranded species, more than 44 h incubation in serum were required to achieve almost complete degradation of the unmodi®ed oligonucleotide D+D (Fig. 5) . At the same time point 30 and 50% of the initial fractions of B+B and C+C, respectively, were still intact (Fig. 5) . Rates of degradation similar to those of C+C were obtained for C2+C2, which contained complementary LNA substitutions as well (Fig. 5 ).
In agreement with our previous observations, the LNA endblock increased the half-life of the decoy in serum from 13.4 to 20.9 h, while insertion of additional LNA substitutions in the kB sites conferred a signi®cant further degree of stabilization as demonstrated by half-lives of C+C and C2+C2 of 39.5 and 34.8 h, respectively (Table 1) . Surprisingly, molecules containing, in addition to the LNA end-block, internal LNA substitutions in non-complementary Figure 5 . Stability of LNA-modi®ed oligonucleotides in human serum. LNA-modi®ed (B+B, C+C, C2+C2, C1+C3, C+C2, C+C3) and control phosphodiester (D+D) decoy molecules were incubated in human serum at 37°C. Aliquots were taken at the time points indicated and then submitted to non-denaturing electrophoretic separation on 2.5% (w/v) agarose gels (a typical experiment is shown). Detection and quanti®cation of the ethidium bromide stained bands corresponding to full-length oligomers were performed in a Gel Doc 1000 apparatus equipped with Molecular Analyst software. The volume density for the time 0 sample was set as the reference value for each incubation. Relative values for the other time point samples in the corresponding incubation were calculated on the basis of this reference value and plotted as a function of incubation time. IC 50 values were calculated by plotting these data as a function of log 10 of the competitor concentration (nM) and ®tting to a dose±response curve.
Curve ®tting was performed with Origin 6.0 Microcal Software. The 50% inhibitory concentrations (nM) T SE are reported in Table 1. positions had half-lives not signi®cantly different (C1+C3, C+C2) or even lower (C+C3) than that of the end-blocked molecule (B+B) ( Table 1 ). These ®ndings demonstrate that in a DNA duplex non-pairing LNA bases are not protective (C1+C3, C+C2), even becoming destabilizing as the space between the LNA bases increases (C+C3). Therefore, it can be concluded that inter-strand positioning of the internal LNA substitutions is a critical parameter for ODN stability, requiring the replacement of complementary nucleotides with LNAs as conditio sine qua non biostability cannot be further improved.
Insertion of a-L-LNA monomers in the kB site increases NF-kB binding af®nity although the intra-strand positioning effect remains
Recently, a diastereoisomeric form of LNA, a-L-LNA (a-Lribo-con®gured LNA) has been introduced (26) . Both LNA and a-L-LNA monomers are ef®ciently locked in an N-type conformation (Fig. 6) . However, when hybridized to complementary DNA, the LNA has been recognized as an RNA mimic that drives the duplex towards an A-type helix. In contrast, NMR and CD spectroscopic studies of a-L-LNA± DNA duplexes have shown that the local native B-like doublestranded DNA structure is preserved. These results point to a-L-LNA being better described as a DNA mimic (34, 35) . Based on this evidence, we hypothesized that substitution of nucleotides in the kB sites with this LNA diastereoisomer could strongly limit interference with transcription factor binding. For this purpose we have designed two decoy ODNs in which the LNA end-block was maintained, while nucleotides in the kB site positions C and C2 were replaced with a-L-LNA (Fig. 7 , C*+C* and C2*+C2*). The ef®ciency of binding of NF-kB to these molecules was assayed in gel shift competition experiments (Fig. 7 shows a typical experiment) and the data obtained were ®tted to a sigmoidal dose±response curve in order to determine their respective IC 50 values.
The results obtained clearly demonstrate that insertion of a-LLNAs in position C of the kB sites drastically reduces interference with transcription factor binding, as indicated by an IC 50 of 24.83 nM, which is 7-fold lower than the IC 50 value of the corresponding LNA-modi®ed C+C molecule and only 2-fold higher than the IC 50 value of the reference DNA molecule D+D (Table 1) . Conversely, substitution of the nucleotides in position C2 with a-L-LNA monomers resulted in an IC 50 value of 219.7 nM, indicating that this nucleotide is crucial and that an intra-strand positioning effect exists for the a-L-LNA as well. ) and ®tted to a dose± response function (graph on the bottom). The 50% inhibitory concentrations (nM) T SE are reported in Table 1 . In the graph, the unmodi®ed D+D ODN shown in Figure 4 is reported again to allow direct comparison.
Nucleic
a-L-LNA-modi®ed ODNs are resistant to nuclease degradation
Having found a decoy with optimal binding af®nity, we wanted to investigate if insertion of a-L-LNA monomers in the decoy resulted in an increased stability to nuclease degradation, as previously demonstrated for LNA substitutions. To this end, C*+C* and C2*+C2* ODNs were incubated in human serum and their susceptibilities to nuclease action were compared, under the same experimental conditions, to that of the unmodi®ed D+D molecule. As shown in Figure 8 , after 46 h incubation 50% of the initial amount of C*+C* and 65% of C2*+C2* was still uncleaved, while only 10% of the full-length DNA molecule D+D was left (Fig. 8) . Consistent with these observations, the half-lives of these molecules were 3-and 3.6-fold higher than that of the isosequential DNA ODN D+D (Table 1) . Interestingly, C*+C* and C2*+C2* displayed half-lives of 40.6 and 48.2 h, respectively, which were very similar to that of the corresponding LNA-modi®ed molecules C+C and C2+C2 ( Table 1 ), demonstrating that replacement of internal LNAs with a-L-LNAs guaranteed the same degree of protection against nuclease digestion.
DISCUSSION
The use of synthetic ODNs as drugs is a relatively new concept in the ®eld of pharmacology. Indeed, several studies involving oligonucleotide-based therapeutics are already in the preclinical or clinical stages of development. The key objective in the ®eld, however, remains the identi®cation of oligonucleotide analogs providing high in vivo ef®cacy. When pursuing structural modi®cations to improve the pharmacological properties of a DNA molecule, two main goals should be achieved: increased resistance to nuclease degradation and high af®nity for the target. These requirements are dif®cult to reconcile in a decoy ODN, where the ideal modi®cation should, on the one hand, prevent nuclease degradation and, on the other, preserve the molecular interactions with the target transcription factor, in order to retain both the af®nity and the speci®city of recognition. Regarding decoy strategies as gene therapy, one of the major concerns is non-speci®c effects of fully phosphorothioate-substituted ODNs, which have been widely used in basic research (8, 36) . Thus, by analogy with antisense molecules, decoy ODNs where only terminal phosphodiester internucleoside linkages are replaced by phosphorothioate linkages have been proposed because of their decreased propensity for non-speci®c protein binding (18) . Nevertheless, these molecules may still cause toxicity (37) . In addition, terminal phosphorothioation is only expected to protect ODNs from exonuclease degradation, while having little effect on endonuclease activity, which plays an important role in ODN metabolism (38, 39) . Attempts to overcome some of the drawbacks associated with ODN phosphorothioation, i.e. non-speci®c binding and toxicity, have recently involved the use of circular dumb-bell DNA molecules because of their proven resistance to exonucleases (40). These ODNs are constructed by the circularization of the 3¢ and 5¢ ends of the oligonucleotides and enzymatic ligation. However, further advances in this direction will certainly require the use of more sophisticated DNA chemical modi®cations, which have the potential to provide a more exhaustive approach to the problem. In this view, PNA-and LNA-based double-stranded oligonucleotides are currently under investigation as alternative decoy agents. With respect to phosphorothioate, LNA-modi®ed oligonucleotides have clearly been proved to be more resistant to nuclease attack and less toxic and, therefore, more suitable in the design of decoy molecules (41) . Terminal modi®cation with LNA as well as PNA bases is indeed suf®cient to make ODN decoys more resistant to exonuclease and, to a certain extent, endonuclease degradation (21, 42) . This latter effect is thought to be due to the propagation to the unmodi®ed internal DNA fragment of the structural modi®cations introduced at the terminal ends, since both LNA and PNA drive the duplex to adopt a conformation which differs from the standard DNA/DNA B-type geometry (27, 43) . In general, the magnitude of stabilization increases as the number of terminal modi®cations increases. However, depending on the extent of the modi®c-ations introduced, a parallel decrease in the ability of the transcription factor to recognize its target sequence is observed. In this regard, PNA gap-mers have been shown to be resistant to both exo-and endonuclease degradation only when modi®cations involve both terminal ends of the duplex (42) . Unfortunately, these molecules are inef®cient as decoys against the transcription factor Sp1 (20) . In contrast, when PNA end-blocks are positioned on only one strand, resistance to DNase I cleavage was only slightly improved (42) , although these molecules were equally ef®cient as DNA/DNA ODNs in inhibiting Sp1 activation (20) . These results highlight the fact that the percentage of nucleotide analogs introduced in a sequence by the end-capping strategy can be critical for transcription factor binding to the central consensus sequence.
To address these concerns, the possibility of directly protecting the internal DNA segment by inserting additional LNA bases in the binding site has been investigated here. Based on our previous observation that introduction of LNA bases in the kB site further increased ODN stability, although causing a loss of NF-kB binding af®nity (21), a comprehensive analysis of the LNA intra-and inter-strand positioning effect on ODN biostability and af®nity of the target transcription factor has been performed here to address the problem of reconciling these two different aspects. The results presented in this paper demonstrate that a strict correlation between positioning of the internal LNA substitutions and NF-kB binding af®nity exists. Introduction of LNA bases at different positions in the kB site indeed resulted in a different degree of perturbation in the interactions between the transcription factor and its modi®ed target sequence. Nevertheless, by combining the most appropriate intra-and inter-strand LNA positionings, the IC 50 of the resulting molecules C1+C3 and C+C3 was still 9-fold higher than that calculated for the reference DNA ODN, indicating that NF-kB af®nity could not be further improved (Table 1) . Indeed, when LNA nucleotides are incorporated several times in duplexes, as in our case, a cooperative effect of the local conformational changes introduced by each substitution has been observed (27) . On the whole, the result is a change in the overall duplex conformation towards an A-type geometry, which is obviously not optimal to sustain interactions between NF-kB and LNA±DNA mix-mers. In addition to the correct geometry of the duplex, suf®cient¯exibility of the DNA molecule is necessary to support the conformational changes required for NF-kB binding. Indeed, co-crystal structures of NF-kB bound to different kB sites have shown that NF-kB induces DNA bending (33) . Of particular relevance is the fact that in PRDII, the AT-tract appears to be the primary determinant of DNA bending, although these central bases make minimal contacts with the transcription factor (32) . This is analogous to other cases in which non-contacted base pairs can in¯uence protein binding af®nity (44) . Since LNAs are locked in the 3¢-endo conformation they do not possess exibility. Thus, it cannot be excluded that¯exibility of the molecule could also be compromised when central nucleotides are replaced with LNAs.
In comparison with the LNA monomer, its diastereoisomeric form, a-L-LNA, has the advantage of leaving the unmodi®ed part of the molecule unperturbed when it is incorporated into a DNA duplex (35) . The result is that the native overall B-type structure is retained so that conformational perturbations are excluded. Indeed, insertion of a-LLNAs in position C of the kB site permitted almost complete reversal of the adverse effect of LNAs on NF-kB binding. Considering that a-L-LNAs act as a B-type mimic, it can be concluded that perturbations of the interactions between NF-kB and its binding sequence in the C+C molecule mainly occurred at the conformational level, being counteracted by the replacement of internal LNAs with a-L-LNAs.
Unexpectedly, the same conclusions cannot be drawn for position C2. Indeed, insertion of LNAs in C2 strongly perturbed NF-kB binding af®nity. At present, the reason why the nucleotide in position C2 is more critical than the nucleotide in position C when replaced with an LNA nucleotide is not clear, for several reasons. Firstly, this nucleotide does not establish base-speci®c contacts with the transcription factor in any of the NF-kB/DNA crystal structures resolved to date (30, 45) . Secondly, we have shown that the nucleotide remains critical in the context of the Ig-kB site, which is known not to bind HMG I(Y) proteins, excluding the possibility that the loss of af®nity for NF-kB was indirectly produced by perturbation of the HMG I(Y)/DNA interactions. Thirdly, from a theoretical point of view, the conformational changes introduced by the LNA in position C2 on the global duplex geometry should be comparable to those induced by the LNAs in other positions. In contrast to what has been observed for the nucleotide in position C, replacement of internal LNAs in position C2 with a-L-LNAs only partially improved the ability of NF-kB to bind the modi®ed kB sequence, suggesting that other properties of the DNA molecule which do not only concern conformation are affected by LNAs at C2.
In this paper we also report that while the intra-and interstrand positioning of LNAs is important for NF-kB binding af®nity, their inter-strand positioning is critical for stability. Indeed, serum stability assays have con®rmed our previous evidence that ODNs containing additional internal LNAs in both strands are more stable than end-blocked LNA ODNs (Table 1) . Similar results have been obtained by Wahlestedt et al., who showed a signi®cantly higher half-life of antisense LNA±DNA mix-mers than isosequential all-phosphorothioate ODNs and a lesser stability of LNA±DNA gap-mers (41) . However, here we show that, in the context of a doublestranded ODN, improved stability can be achieved only when internal LNA substitutions are placed in complementary positions. As a consequence, by excluding the C2+C2 molecule because of its very poor NF-kB af®nity, C+C was the only molecule tested with a signi®cantly increased stability in comparison with the LNA end-modi®ed (B+B) ODN, but also with a lower af®nity ( Table 1 ). The 16-fold decrease in af®nity of C+C could not be of secondary importance in terms of activity considering that the predicted binding af®nity of NF-kB is extremely high due to the low abundance of this transcription factor within cells (46) . However, we here demonstrate that the problem of increasing stability while maintaining high binding af®nity can be solved by replacing nucleotides at position C in the kB sequence with a-L-LNAs. Signi®cantly, introduction of a-L-LNAs conferred the same degree of stability as obtained with LNAs, while they did not interfere with NF-kB binding. Indeed, the competition ef®ciency of the C*+C* ODN containing a-L-LNAs was only 2-fold lower than that of the corresponding DNA ODN, allowing us to predict a K d value of the same order of magnitude as the unmodi®ed ODN (Table 1) .
In conclusion, this study highlights the importance of LNA positioning in a decoy molecule when substitutions are also introduced within the transcription factor binding sequence in order to improve resistance to nuclease digestion. This work has revealed which nucleotides are most crucial for NF-kB binding when replaced with LNAs or their diastereoisomeric forms, a-L-LNAs. At the same time, we have identi®ed those nucleotides which are not crucial, implying that these residues could be modi®ed to increase nuclease resistance. However, we also show that LNA interference is not only dependent on positioning, but also on intrinsic conformational properties. In this context, a-L-LNAs, as DNA mimics, permit minimization of this latter effect, while maintaining high stability. This evidence emphasizes the importance of addressing the appropriate chemical modi®cation to overcome many of the problems which limit engineering of ODN decoys to the end-capping. To our knowledge, the results presented here are the very ®rst report on the feasibility of nucleotide modi®ca-tions in the binding site of a decoy molecule without loss of af®nity and/or speci®city and provide further insights into the usage of LNAs and their positioning in the design of decoy ODNs. The results obtained with a-L-LNA-modi®ed ODNs encourage further studies focused on testing their ef®cacy in cellular experimental systems. In this regard, delivery of a-L-LNA-based decoys against NF-kB to the monocyte/macrophagic compartment are in progress with the goal of achieving long-term modulation of NF-kB activation and as a consequence controlled release of pro-in¯ammatory mediators in pathological conditions such as chronic in¯ammation and autoimmunity (47) .
